Related Experiment Video
Updated: Jun 17, 2026
Models of Bone Metastasis
Published on: September 4, 2012
MEPE's diverse effects on mineralization
Adele L Boskey1, Phyllis Chiang, Alexis Fermanis
1Musculoskeletal Integrity Program, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA. Boskeya@hss.edu
Abstract:
Matrix extracellular phosphoglycoprotein (MEPE) is an inhibitor of mineralization in situ and in cell cultures where altered expression is associated with oncogenic osteomalacia and hypophosphatemic rickets. The purpose of this study was to determine whether the intact protein or the peptide(s) originating from this protein was responsible for the inhibition. The ability of the intact protein and the acidic, serine- and aspartate-rich MEPE-associated motif (ASARM) peptide to promote or inhibit de novo hydroxyapatite formation and growth of hydroxyapatite seed crystals, in both phosphorylated and dephosphorylated forms, was assessed at room temperature in a dynamic gel diffusion system at 3.5 and 5 days. The most effective nucleator concentration was also examined when associated with fibrillar type I collagen. The phosphorylated intact protein was an effective promoter of mineralization in the gelatin gel diffusion system, while the ASARM peptide was an effective inhibitor. When dephosphorylated both the intact protein and the ASARM peptide had no effect on mineralization. Associated with collagen fibrils, some of the effect of the intact protein was lost. This study demonstrates the importance of posttranslational modification for the site-specific activity of MEPE and its ASARM peptide.
Insights
Matrix extracellular phosphoglycoprotein (MEPE) and its ASARM peptide regulate mineralization. Phosphorylation is crucial for MEPE
Area of Science:
- Biochemistry
- Mineralization Biology
- Skeletal Biology
Background:
- Matrix extracellular phosphoglycoprotein (MEPE) is implicated in mineralization disorders like hypophosphatemic rickets.
- Altered MEPE expression is linked to oncogenic osteomalacia and rickets.
- MEPE's role in mineralization requires further elucidation.
Purpose of the Study:
- To discern whether intact MEPE or its derived peptides inhibit mineralization.
- To investigate the role of phosphorylation in MEPE and ASARM peptide activity.
- To assess MEPE and ASARM peptide interactions with collagen.
Main Methods:
- Dynamic gel diffusion system used to assess de novo hydroxyapatite formation.
- Hydroxyapatite seed crystal growth evaluated for phosphorylated and dephosphorylated MEPE and ASARM peptide.
- Effect of MEPE and ASARM peptide on mineralization in the presence of type I collagen.
Main Results:
- Phosphorylated intact MEPE promoted mineralization, while the ASARM peptide inhibited it.
- Dephosphorylated MEPE and ASARM peptide showed no effect on mineralization.
- Association with collagen fibrils partially diminished the intact MEPE protein's effect.
Conclusions:
- Post-translational modification, specifically phosphorylation, is critical for MEPE and ASARM peptide activity.
- MEPE's function in mineralization is dependent on its phosphorylation state.
- These findings highlight the regulatory role of MEPE in skeletal mineralization.
Related Concept Videos
02:17The Tumor Microenvironment
01:15Drugs that Stabilize Microtubules